Market Overview:
Liver Cancer Drug Markrt is the third leading cause of cancer death worldwide. The major risk factors for liver cancer include hepatitis B and C infections, alcohol abuse, cirrhosis, and obesity. The incidence of liver cancer is increasing globally, due to the rising prevalence of these risk factors.
Global Liver Cancer Drugs market was valued at US$ 980 million in 2023 and 2032, this market is estimated to register the highest CAGR of 9.3%.
– Please check this report :@https://market.us/report/liver-cancer-drugs-market/
Market Recent Development:
- Jan 2023, SURVCAN-3 a population based study in32 countries for survival of cancer in Central South America, Africa and Asia by Global Cancer Observatory
- Jan 2022, On the basis of its second confirmatory research, Merck gained conditional clearance for the liver cancer therapy medicine Keytruda. In Asia region, hepatocellular carcinoma’s patients, reduced the risk of death by 21% by Keytruda.
- Mar 2021, Glass Microspheres TheraSphere Y-90 , manufactured by Boston Scientific Corporation for the care of patients with hepatocellular cancer (HCC), have been given FDA approval.
Market Key Players:
- Eli Lilly and Company
- Exelixis Inc.
- Merck Co. Inc.
- Pfizer Inc.
- AbbVie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Johnson Johnson
- Sanofi SA
Regional Analysis:
-North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]mailto:inquiry@market.us
Market Top Segmentation:
By Origin Type
- Benign Liver Growths
- Secondary
- Primary
By Type
- Hepatocellular Carcinoma
- Hepatoblastoma
- Cholangio carcinoma
- Other Types
By Therapy
- Targeted Therapy
- Chemotherapy
- Immunotherapy
- Radiation Therapy
By End User
- Adult
- Pediatrics
Make an inquiry before picking up this report @
Market Trends:
- The rise of targeted therapies and immunotherapies
- The growing pipeline of novel Liver Cancer drugs
- The increasing incidence of liver cancer in emerging markets
- The increasing focus on personalized medicine
Contact:
Global Business Development Team – Market.us
Market.us (Powered by Prudour Pvt. Ltd.)
Send Email: inquiry@market.us
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Tel: +1 718 618 4351
Website: https://market.us
